NODAL and breast cancer: The results indicate that colony formation by both MDA-MB-231 and MDA-MB-468 cells treated with anti-Nodal blocking antibody was significantly reduced as compared to untreated or IgG treated control cells (Figure 5B), thus demonstrating the efficacy of targeting the tumorigenic potential of Nodal-expressing breast cancer cells.